Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5702168 | Practical Radiation Oncology | 2017 | 20 Pages |
Abstract
DIBH reduced ipsilateral lung V20Gy by â¥5% in the majority of patients. For some patients, the volume of liver receiving a potentially toxic dose decreased with DIBH. DIBH should be available as a treatment strategy to reduce ipsilateral lung V20Gy prior to compromising internal mammary chain nodal coverage for patients with right-sided breast cancer during locoregional radiation therapy if the V20Gy on FB exceeds 30%.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jessica L. MD, Leigh Conroy, Lindsay Harper, Marie Scheifele, Haocheng PhD, Wendy L. PhD, Tannis Graham, Tien MD, Ivo A. MD,